We are live on
!
Find out more
SC
Sophrosyne Capital Portfolio holdings
AUM
$11.5M
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
+21.25%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow
% of AUM
95.08%
Top 10 Holdings %
Top 10 Hldgs %
56.2%
Holding
52
New
52
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$11.6M |
| 2 |
Calix
CALX
|
+$10.1M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$6.92M |
| 4 |
Lesaka Technologies
LSAK
|
+$6.86M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$6.55M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 45.91% |
| 2 | Technology | 33.09% |
| 3 | Materials | 4.86% |
| 4 | Miscellaneous | 4.56% |
| 5 | Communication Services | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Assembly Biosciences
ASMB
$709M
| $1.4M | 1.1% |
+9,719
| New | +$1.52M |
|
|
ICAD
27
DELISTED
iCAD Inc
ICAD
| $1.37M | 1.08% |
+228,891
| New | +$1.26M |
|
28
Altimmune
ALT
$630M
| $1.28M | 1% |
+2,683
| New | +$1.33M |
|
|
SQNS
29
Sequans Communications SA
SQNS
$44.3M
| $1.07M | 0.84% |
+7,113
| New | +$1.08M |
|
|
CUTR
30
DELISTED
Cutera, Inc.
CUTR
| $1.04M | 0.81% |
+118,000
| New | +$1.22M |
|
31
Sarepta Therapeutics
SRPT
$2.28B
| $1.02M | 0.8% |
+26,800
| New | +$958K |
|
|
P
32
DELISTED
Pandora Media Inc
P
| $946K | 0.74% |
+51,400
| New | +$769K |
|
|
ENVI
33
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
| $815K | 0.64% |
+403,528
| New | +$690K |
|
34
Logitech
LOGI
$14B
| $663K | 0.52% |
+94,200
| New | +$642K |
|
|
RDA
35
DELISTED
RDA MICROELECTRONICS INC SPONSORED ADR
RDA
| $661K | 0.52% |
+59,700
| New | +$606K |
|
36
Riot Platforms
RIOT
$7.84B
| $558K | 0.44% |
+58,115
| New | +$754K |
|
|
STRM
37
DELISTED
Streamline Health Solutions
STRM
| $557K | 0.44% |
+5,653
| New | +$554K |
|
38
Limoneira
LMNR
$246M
| $490K | 0.38% |
+23,629
| New | +$458K |
|
|
PRKR
39
DELISTED
Parkervision Inc
PRKR
| $465K | 0.36% |
+10,220
| New | +$420K |
|
|
CPRX
40
DELISTED
Catalyst Pharmaceutical
CPRX
| $458K | 0.36% |
+510,000
| New | +$408K |
|
|
HDSN
41
Hudson Technologies
HDSN
$231M
| $408K | 0.32% |
+127,974
| New | +$467K |
|
|
RTK
42
DELISTED
Rentech, Inc.
RTK
| $403K | 0.32% |
+19,206
| New | +$415K |
|
|
VWTR
43
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $354K | 0.28% |
+16,900
| New | +$370K |
|
44
Tower Semiconductor
TSEM
$24.8B
| $317K | 0.25% |
+66,479
| New | +$416K |
|
45
Safe Bulkers
SB
$857M
| $239K | 0.19% |
+44,961
| New | +$229K |
|
46
Canadian Pacific Kansas City
CP
$82.5B
| $229K | 0.18% |
+9,425
| New | +$237K |
|
47
Lifecore Biomedical
LFCR
$172M
| $211K | 0.17% |
+16,000
| New | +$221K |
|
48
FMC
FMC
$1.33B
| $180K | 0.14% |
+3,401
| New | +$179K |
|
|
TEAR
49
DELISTED
TearLab Corporation
TEAR
| $136K | 0.11% |
+1,280
| New | +$117K |
|
50
Ecolab
ECL
$80.1B
| $94K | 0.07% |
+1,100
| New | +$92.9K |
|
Similar funds
SFM
IACGFA
LS
NGPI
AP
GRP
NVPV
AC
Sophrosyne Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Sophrosyne Capital, which disclosed 52 positions worth $128M. Its ten largest holdings account for 56% of the portfolio.
Its largest position is Strategy Inc: 1,244,630 shares worth $10.8M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, followed by Technology and Materials.
- Sophrosyne Capital's largest Q2 2013 buy was Strategy Inc: 1,244,630 shares worth $10.8M.
- Sophrosyne Capital's ten largest holdings make up 56% of its $128M portfolio in Q2 2013.
- Sophrosyne Capital disclosed 52 positions in Q2 2013, its first 13F filing on record.
Based on Sophrosyne Capital's 13F filing for Q2 2013, filed 14 Aug 2013.